Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Researchers have found that a small vaccine, currently in its early trial phase, can enhance immune system response to fight ...

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...